Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

1,360 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Timing the end of nocturnal sleep.
Born J, Hansen K, Marshall L, Mölle M, Fehm HL. Born J, et al. Among authors: marshall l. Nature. 1999 Jan 7;397(6714):29-30. doi: 10.1038/16166. Nature. 1999. PMID: 9892349 No abstract available.
Insecticidal proteins from Bacillus thuringiensis protect corn from corn rootworms.
Moellenbeck DJ, Peters ML, Bing JW, Rouse JR, Higgins LS, Sims L, Nevshemal T, Marshall L, Ellis RT, Bystrak PG, Lang BA, Stewart JL, Kouba K, Sondag V, Gustafson V, Nour K, Xu D, Swenson J, Zhang J, Czapla T, Schwab G, Jayne S, Stockhoff BA, Narva K, Schnepf HE, Stelman SJ, Poutre C, Koziel M, Duck N. Moellenbeck DJ, et al. Among authors: marshall l. Nat Biotechnol. 2001 Jul;19(7):668-72. doi: 10.1038/90282. Nat Biotechnol. 2001. PMID: 11433280
Brain stem death induces pro-inflammatory cytokine production and cardiac dysfunction in sheep model.
Walweel K, Boon AC, See Hoe LE, Obonyo NG, Pedersen SE, Diab SD, Passmore MR, Hyslop K, Colombo SM, Bartnikowski NJ, Bouquet M, Wells MA, Black DM, Pimenta LP, Stevenson AK, Bisht K, Skeggs K, Marshall L, Prabhu A, James LN, Platts DG, Macdonald PS, McGiffin DC, Suen JY, Fraser JF. Walweel K, et al. Among authors: marshall l. Biomed J. 2021 Oct 16:S2319-4170(21)00142-6. doi: 10.1016/ Online ahead of print. Biomed J. 2021. PMID: 34666219
Treatment outcome with a selective RET tyrosine kinase inhibitor selpercatinib in children with multiple endocrine neoplasia type 2 and advanced medullary thyroid carcinoma.
Shankar A, Kurzawinski T, Ross E, Stoneham S, Beale T, Proctor I, Hulse T, Simpson K, Gaze MN, Cattaneo E, Gevers E, Marshall L, Hubbard JG, Brain C. Shankar A, et al. Among authors: marshall l. Eur J Cancer. 2021 Oct 11;158:38-46. doi: 10.1016/j.ejca.2021.09.012. Online ahead of print. Eur J Cancer. 2021. PMID: 34649088
Pubertal development in 46,XY patients with NR5A1 mutations.
Mönig I, Schneidewind J, Johannsen TH, Juul A, Werner R, Lünstedt R, Birnbaum W, Marshall L, Wünsch L, Hiort O. Mönig I, et al. Among authors: marshall l. Endocrine. 2021 Oct 6. doi: 10.1007/s12020-021-02883-y. Online ahead of print. Endocrine. 2021. PMID: 34613524
A cost-effectiveness and budget impact analysis of C-reactive protein point-of-care testing to guide antibiotic prescribing for acute respiratory tract infections in primary care settings in Ireland: a decision-analytic model.
Fawsitt CG, Lucey D, Harrington P, Jordan K, Marshall L, O'Brien KK, Teljeur C. Fawsitt CG, et al. Among authors: marshall l. Fam Pract. 2021 Sep 30:cmab123. doi: 10.1093/fampra/cmab123. Online ahead of print. Fam Pract. 2021. PMID: 34591966
Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis.
Sandborn WJ, Feagan BG, D'Haens G, Wolf DC, Jovanovic I, Hanauer SB, Ghosh S, Petersen A, Hua SY, Lee JH, Charles L, Chitkara D, Usiskin K, Colombel JF, Laine L, Danese S; True North Study Group. Sandborn WJ, et al. N Engl J Med. 2021 Sep 30;385(14):1280-1291. doi: 10.1056/NEJMoa2033617. N Engl J Med. 2021. PMID: 34587385
First-in-child phase I/II study of the dual mTORC1/2 inhibitor vistusertib (AZD2014) as monotherapy and in combination with topotecan-temozolomide in children with advanced malignancies: arms E and F of the AcSé-ESMART trial.
Morscher RJ, Brard C, Berlanga P, Marshall LV, André N, Rubino J, Aerts I, De Carli E, Corradini N, Nebchi S, Paoletti X, Mortimer P, Lacroix L, Pierron G, Schleiermacher G, Vassal G, Geoerger B. Morscher RJ, et al. Among authors: marshall lv. Eur J Cancer. 2021 Sep 17;157:268-277. doi: 10.1016/j.ejca.2021.08.010. Online ahead of print. Eur J Cancer. 2021. PMID: 34543871
Second Paediatric Strategy Forum for anaplastic lymphoma kinase (ALK) inhibition in paediatric malignancies: ACCELERATE in collaboration with the European Medicines Agency with the participation of the Food and Drug Administration.
Pearson ADJ, Barry E, Mossé YP, Ligas F, Bird N, de Rojas T, Zimmerman ZF, Wilner K, Woessmann W, Weiner S, Weigel B, Venkatramani R, Valteau D, Trahair T, Smith M, Singh S, Selvaggi G, Scobie N, Schleiermacher G, Richardson N, Park J, Nysom K, Norga K, Merino M, McDonough J, Matloub Y, Marshall LV, Lowe E, Lesa G, Irwin M, Karres D, Gajjar A, Doz F, Fox E, DuBois SG, Donoghue M, Casanova M, Caron H, Buenger V, Bradford D, Blanc P, Barone A, Reaman G, Vassal G. Pearson ADJ, et al. Among authors: marshall lv. Eur J Cancer. 2021 Sep 15;157:198-213. doi: 10.1016/j.ejca.2021.08.022. Online ahead of print. Eur J Cancer. 2021. PMID: 34536944 Free article. Review.
1,360 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page